Abstract
Reciprocal rearrangements of the MLL gene are among the most common chromosomal abnormalities in both Acute Lymphoblastic and Myeloid Leukemia. The MLL gene, located on the 11q23 chromosomal band, is involved in more than 40 recurrent translocations. In the present study, we describe the development and validation of a biochip-based assay designed to provide a comprehensive molecular analysis of MLL rearrangements when used in a standard clinical pathology laboratory. A retrospective blind study was run with cell lines (n=5), and MLL positive and negative patient samples (n=31), to evaluate assay performance. The limits of detection determined on cell line data were 10−1, and the precision studies yielded 100% repeatability and 98% reproducibility. The study shows that the device can detect frequent (AF4, AF6, AF10, ELL or ENL) as well as rare partner genes (AF17, MSF). The identified fusion transcripts can then be used as molecular phenotypic markers of disease for the precise evaluation of minimal residual disease by RQ-PCR. This biochip-based molecular diagnostic tool allows, in a single experiment, rapid and accurate identification of MLL gene rearrangements among 32 different fusion gene (FG) partners, precise breakpoint positioning and comprehensive screening of all currently characterized MLL FGs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rowley JD . The critical role of chromosome translocations in human leukemias. Annu Rev Genet 1998; 32: 495–519.
DiMartino JF, Cleary ML . MLL rearrangements in haematological malignancies: lessons from clinical and biological studies. Br J Haematol 1999; 106: 614–626.
Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa III R, Patel Y, Harden A et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991; 88: 10735–10739.
Bernard OA, Berger R . Molecular basis of 11q23 rearrangements in haematopoietic malignant proliferations. Genes Chromosomes Cancer 1995; 13: 75–85.
Collins EC, Rabbits TH . The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism. Trends Mol Med 2002; 8: 436–442.
Hayette S, Tigaud I, Maguer-Satta V, Bartholin L, Thomas X, Charrin C et al. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood 2002; 99: 4647–4649.
Huret JL Infobiogen. Atlas Genet Cytogenet Oncol Haematol. 11q23 rearrangements in leukaemia. http://www.infobiogen.fr/services/chromcancer/Anomalies/11q23ID1030.html (Accessed October 2003).
Biondi A, Cimino G, Pieters R, Pui CH . Biological and therapeutic aspects of infant leukemia. Blood 2000; 96: 24–33.
Bloomfield CD, Archer KJ, Mrozek K, Lillington DM, Kaneko Y, Head DR et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33: 362–378.
Pui CH, Relling MV . Topoisomerase II inhibitor-related acute myeloid leukaemia. Br J Haematol 2000; 109: 13–23.
Secker-Walker LM . General Report on the European Union Concerted Action Workshop on 11q23, London UK, May 1997. Leukemia 1998; 12: 776–778.
Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97: 2145–2150.
Caligiuri MA, Strout MP, Oberkircher AR, Yu F, de la Chapelle A, Bloomfield CD . The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome. Proc Natl Acad Sci USA 1997; 94: 3899–3902.
Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.
Martinez-Climent JA, Espinosa III R, Thirman MJ, Le Beau MM, Rowley JD . Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival. J Pediatr Hematol Oncol 1995; 17: 277–283.
Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41–47.
Ayton PM, Cleary ML . Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 2001; 20: 5695–5707.
Cuthbert G, Thompson K, Breese G, McCullough S, Bown N . Sensitivity of FISH in detection of MLL translocations. Genes Chromosomes Cancer 2000; 29: 180–185.
Mathew S, Behm F, Dalton J, Raimondi S . Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities. Leukemia 1999; 13: 1713–1720.
van der Burg M, Beverloo HB, Langerak AW, Wijsman J, van Drunen E, Slater R et al. Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set. Leukemia 1999; 13: 2107–2113.
von Bergh A, Emanuel B, van Zelderen-Bhola S, Smetsers T, van Soest R, Stul M et al. A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias. Genes Chromosomes Cancer 2000; 28: 14–22.
Cox MC, Maffei L, Buffolino S, Del Poeta G, Venditti A, Cantonetti M et al. A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias. Am J Clin Pathol 1998; 109: 24–31.
Pallisgaard N, Hokland P, Riishoj DC, Pedersen B, Jorgensen P . Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood 1998; 92: 574–588.
Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J et al. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 1995; 9: 210–215.
Strehl S, Konig M, Mann G, Haas OA . Multiplex reverse transcriptase-polymerase chain reaction screening in childhood acute myeloblastic leukemia. Blood 2001; 97: 805–808.
Shi RZ, Morrissey JM, Rowley JD . Screening and quantification of multiple chromosome translocations in human leukemia. Clin Chem 2003; 49: 1066–1073.
Nasedkina T, Domer P, Zharinov V, Hoberg J, Lysov Y, Mirabekov A . Identification of chromosomal translocations in leukemias by hybridization with oligonucleotide microarrays. Haematologica 2002; 87: 363–372.
Rasio D, Schichman SA, Negrini M, Canaani E, Croce CM . Complete exon structure of the ALL1 gene. Cancer Res 1996; 56: 1766–1769.
Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292–2302.
Tanabe S, Zeleznik-Le NJ, Kobayashi H, Vignon C, Espinosa III R, LeBeau MM et al. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line. Genes Chromosomes Cancer 1996; 15: 206–216.
Scholl C, Breitinger H, Schlenk RF, Döhner H, Fröhling S, Döhner K . AML Study Group Ulm. Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute leukemia. Genes Chromosomes Cancer 2003; 38: 274–280.
Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – a Europe Against Cancer Program. Leukemia 2003; 17: 2318–2357.
Caldas C, So CW, MacGregor A, Ford AM, McDonald B, Chan LC et al. Exon scrambling of MLL transcripts occur commonly and mimic partial genomic duplication of the gene. Gene 1998; 208: 167–176.
Nam DK, Honoki K, Yu M, Yunis JJ . Alternative RNA splicing of the MLL gene in normal and malignant cells. Gene 1996; 178: 169–175.
Gozzetti A, Le Beau MM . Fluorescence in situ hybridizations: uses and limitations. Semin Hematol 2000; 37: 320–333.
Kreuzer KA, Lass U, Landt O, Nitsche A, Laser J, Ellbrock H et al. Highly sensitive and specific fluorescence reverse transcription PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem 1999; 45: 297–300.
Pui CH . Acute lymphoblastic leukemia in children. Curr Opin Oncol 2000; 12: 3–12.
Rubnitz JE, Raimondi SC, Tong X, Srivastava DK, Razzouk BI, Shurtleff SA et al. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 2002; 20: 2302–2309.
Rabbitts TH, Stocks MR . Chromosomal translocation products engender new intracellular therapeutic technologies. Nat Med 2003; 9: 383–386.
Acknowledgements
We thank Dr C Bilhou Nabera (CHU, Bordeaux, France) and Dr N Dastugue (Hôpital Purpan, Toulouse, France) for providing samples, Dr D Birnbaum (IPC, Marsèille, France) for critical review of the manuscript, and Dr P Ravassard (LGN, Paris, France) for valuable discussion. We also gratefully acknowledge Ipsogen's Bioinformatics and Production Teams for their contributions. This work was partially supported by grants from PHRC97 (JG), the Agence Nationale de la Valorisation de la Recherche (ANVAR) and the Directions Régionales de l'Industrie de la Recherche et de l'Environnement (DRIRE).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maroc, N., Morel, A., Beillard, E. et al. A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia. Leukemia 18, 1522–1530 (2004). https://doi.org/10.1038/sj.leu.2403439
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403439
This article is cited by
-
Diagnostic Microarrays in Hematologic Oncology
Molecular Diagnosis & Therapy (2009)
-
A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25)
International Journal of Hematology (2008)
-
Identification of Leukemia-Specific Fusion Gene Transcripts with a Novel Oligonucleotide Array
Molecular Diagnosis & Therapy (2007)
-
MicroArray Facility: a laboratory information management system with extended support for Nylon based technologies
BMC Genomics (2006)